Opendata, web and dolomites


A new clinically proven and reliable medical solution for continuous heart arrhythmia and blood pressure monitoring

Total Cost €


EC-Contrib. €






 CARDIACSENSE project word cloud

Explore the words cloud of the CARDIACSENSE project. It provides you a very rough idea of what is the project "CARDIACSENSE" about.

detects    sense    small    individuals    ltd    data    error    cardiac    yearly    obtrusive    patients    vital    stroke    htn    finalize    365    suffering    medical    cardiacsense    consists    fibrillation    first    invasive    boost    mainly    healthcare    800m    arrhythmia    surgery    delivers    500bn    encountered    risk    signs    sensitive    launch    ppg    risks    costing    5m    save    proven    time    sharing    heart    mostly    sensor    lives    bp    solution    finger    training    start    accuracy    israeli    measuring    precise    ischaemic    trl6    20    half    500    storage    wrist    positive    inflating    vision    lack    besides    introducing    optical    pressure    continuous    unaware    23    2025    monitor    innovative    2009    adults    free    jobs    atrial    false    device    movements    wearable    af    blood    pulse    artefact    hypertension    watch    health    connectivity    monitoring    clinically    revenues    market    globally    signal    reliably    grade    company   

Project "CARDIACSENSE" data sheet

The following table provides information about the project.


Organization address
address: 4 LESHEM ST
postcode: 3079825
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Project website
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2018
 Duration (year-month-day) from 2018-12-01   to  2019-03-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CARDIACSENSE IL (CAESARA) coordinator 50˙000.00


 Project objective

Atrial fibrillation (AF) is the most common heart arrhythmia in adults and a major risk factor for ischaemic stroke (increased by 500%), costing globally around €500Bn/year. On the other hand, Hypertension (HTN) is a condition, mostly encountered in patients suffering from AF, although only half of these individuals have this condition under control, and only 20% are unaware that they have HTN. Besides the health risks associated with these conditions, there is a lack of non-obtrusive, non-inflating, non-invasive, small, precise, easy-to-use devices for continuous monitoring of vital signs, including AF and blood pressure. Cardiac Sense Ltd is an Israeli start-up established in 2009, with a vision of developing innovative non-invasive technology for monitoring vital signs. We are developing CardiacSense (TRL6), a clinically-proven medical solution that reliably delivers non-invasive and non-inflating heart arrhythmia and blood pressure monitoring, 23/365 for as long as needed. It mainly consists of a wearable (a watch), highly sensitive, error-free (introducing an artefact sensor), real-time measuring device, that is non-invasive (no surgery needed), easy to use (no training needed) and allows for a great connectivity (providing easy data storage and sharing). Our solution is based on optical PPG sensor technology to monitor heart AF and BP. In addition, we are the first company to develop a unique artefact sensor that detects finger and wrist movements that affect the PPG signal by increasing false positive results. Our solution thus has a medical grade accuracy level of pulse measurement. Through this project we aim to finalize its development and launch it to the market, with a potential to save around €800M to EU healthcare and save up to 5,000 lives yearly, and to boost our company's growth to €7.5M revenues, and 20 new jobs by 2025.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "CARDIACSENSE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "CARDIACSENSE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

PrasinoMed (2018)

First in the world ecological and sustainable cream for wound care, based on microalgaprasinococcus capsulatus

Read More  

GREEN WHS (2019)


Read More  

In-Heal (2019)

Standardised administration device for raw medical herbs

Read More